Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

Combining her technology degree with liberal arts provided Diana Solt the powerful combination she needed to develop business strategies for L3/Harris. Tinkering, testing, designing, coding – it's ...